Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Net Margin (2016 - 2025)

Xtant Medical Holdings has reported Net Margin over the past 16 years, most recently at 3.93% for Q3 2025.

  • Quarterly Net Margin rose 2192.0% to 3.93% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1.32% through Sep 2025, up 1843.0% year-over-year, with the annual reading at 14.03% for FY2024, 1267.0% down from the prior year.
  • Net Margin was 3.93% for Q3 2025 at Xtant Medical Holdings, down from 10.03% in the prior quarter.
  • Over five years, Net Margin peaked at 36.9% in Q3 2023 and troughed at 22.07% in Q4 2023.
  • The 5-year median for Net Margin is 11.58% (2023), against an average of 7.6%.
  • Year-over-year, Net Margin soared 5317bps in 2023 and then crashed -5488bps in 2024.
  • A 5-year view of Net Margin shows it stood at 17.04% in 2021, then grew by 15bps to 14.47% in 2022, then tumbled by -53bps to 22.07% in 2023, then skyrocketed by 54bps to 10.04% in 2024, then surged by 139bps to 3.93% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Net Margin are 3.93% (Q3 2025), 10.03% (Q2 2025), and 0.18% (Q1 2025).